Compare Kenvue Inc. Common Stock (KVUE) vs UiPath Inc (PATH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs UiPath Inc — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while UiPath Inc trades at $13.5 (market cap $6.91B). The key difference: Kenvue Inc. Common Stock is far larger — about 4.9× UiPath Inc's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while UiPath Inc pays none. Which is the better fit depends on your goals.
| KVUE | PATH | |
|---|---|---|
Market Cap | $34.06B | $6.91B |
Volume | 23,267,228 | 34,321,250 |
Sector | Consumer Staples | Technology |
52-Week High | $19.83 | $19.29 |
52-Week Low | $14.11 | $9.38 |
Enterprise Value | $41.56B | $5.70B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 139 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
UiPath (PATH) trades at $13.45, up 2.87% today, showing technical bullish momentum despite mixed earnings. The company demonstrates strong revenue growth from $1.43B in 2025 to projected $1.7B in 2026, with net income turning positive at $362M. Recent partnerships with Snowflake and BDO highlight strategic expansion in AI orchestration, while analyst consensus remains cautious with 67% hold ratings.
PATH offers growth potential through AI automation leadership but faces execution risks amid competitive pressures. The stock trades below consensus target of $15.13, suggesting 12% upside if guidance is met. Key risks include pricing pressure and integration challenges with new partnerships.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About UiPath Inc
UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →
